Hemoperitoneum is an initial presentation of recurrent granulosa cell tumors of the ovary.
Ovarian sex cord-stromal tumors account for less than 5% of all ovarian carcinoma, of which granulosa cell tumors account for 70%. These tumors have a propensity for indolent growth and late recurrence; they may even occur 25 years after initial treatment. We report a 44-year-old woman with hemoperitoneum (acute abdomen) after initial treatment 10 years earlier for granulosa cell tumor of the ovary. This case re-emphasizes the need for long-term follow-up in patients with stromal cell tumors of the ovary and considers the possibility of recurrence when presented with acute abdomen after conservative treatment.
Lee
W L
WL
Department of Medicine, Veterans General Hospital, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Yuan
C C
CC
Lai
C R
CR
Wang
P H
PH
D000006:Abdomen, Acute / Q000209:etiology; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006106:Granulosa Cell Tumor / Q000150:complications* / Q000473:pathology / Q000628:therapy; D006465:Hemoperitoneum / Q000209:etiology*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000628:therapy; D010051:Ovarian Neoplasms / Q000150:complications* / Q000473:pathology / Q000628:therapy; D010052:Ovariectomy
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin